Testing a new eye injection to slow vision loss from retinal damage

This trial is testing a new medication called pozelimab, which is injected directly into the eye. The study wants to find out if this medication is safe and causes acceptable side effects in people with geographic atrophy—a condition where parts of the retina gradually stop working, leading to vision loss. Researchers will also track how much of the medication stays in your eye and blood, and whether your body develops a reaction against it.

Geographic atrophy is a serious form of age-related vision loss that currently has limited treatment options. This trial exists to test whether this new treatment can help slow or prevent further damage to the retina without causing serious harm.